Sibylle Loibl discusses recent advances in the treatment of oestrogen receptor positive, HER2-positive, and triple-negative breast cancers.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
